4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001415889-25-022440
GENERAL COUNSEL & CORP SEC sold 1,683 shares at $18.24 ($30,695)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2025-08-18 | Sale | −1,683 | $18.24 | $30,695 | 23,948 | D |
| Open-market sales · 1,683 sh · avg $18.24 · $30,695 | |||||||
Loading xslF345X05/form4-08202025_080802.xml…